Guangdong Hybribio Biotech: Stock trading has experienced abnormal fluctuations announcement.
Guangdong Hybribio Biotech: Announcement Regarding the Progress of the Second Repurchase of Company Shares through Centralized Auction Trading Method in 2024
Guangdong Hybribio Biotech: Announcement regarding the company and its subsidiaries being granted invention patent authorization.
Guangdong Hybribio Biotech: Announcement about the change of medical instrument production license for a wholly-owned subsidiary.
Guangdong Hybribio Biotech: Announcement Regarding Partial Stocks and Options Cancellation for the 2021 Stock Options Incentive Plan
Guangdong Hybribio Biotech: Announcement of Resolutions from the 20th Meeting of the 5th Board of Directors.
Guangdong Hybribio Biotech: Legal Opinion of Guangdong Xinda Law Firm on Matters Related to the Company's 2021 Stock Option Incentive Plan
Guangdong Hybribio Biotech: Announcement of Resolutions of the Fifteenth Meeting of the Fifth Session of the Supervisory Board.
Guangdong Hybribio Biotech: Announcement Regarding the Cancellation of Some Stock Options.
Guangdong Hybribio Biotech: Announcement Regarding the Progress of the Second Repurchase of Company Shares through Centralized Auction Trading Method in 2024
Guangdong Hybribio Biotech: Announcement on the first repurchase of company shares through centralized bidding trading in the plan for the second repurchase of company shares in 2024.
Guangdong Hybribio Biotech: Announcement on the top ten shareholders and top ten unrestricted shareholders' holdings of the company's repurchased shares in the second centralized bidding trade in 2024.
Guangdong Hybribio Biotech: Announcement of Resolution of the 14th Meeting of the Fifth Board of Supervisors.
Guangdong Hybribio Biotech: Announcement regarding the plan of buying back the company's shares by centralized bidding trade in 2024 for the second time.
Guangdong Hybribio Biotech: Report on the repurchase of company shares by centralized bidding trading for the second time in 2024.
Guangdong Hybribio Biotech: Announcement of the resolution of the 19th meeting of the 5th board of directors.
Guangdong Hybribio Biotech: Announcement about supplemental pledge of shares for shareholders holding more than 5% of the company's shares.
Guangdong Hybribio Biotech: Announcement about the wholly-owned subsidiary obtaining the registration certificate for medical instruments.
Guangdong Hybribio Biotech: Announcement Regarding the Company and Its Wholly-owned Subsidiaries Obtaining Notification of Patent Grant for Invention.
Guangdong Hybribio Biotech: Announcement Regarding Company and Its Subsidiaries Receiving Notice of Grant of Patent Rights
No Data